It’s all about money, and you’re just another sale to them. The neuropathy pain market hit $5.84 billion in 2023, but instead of finding cures, they’re cashing in on the growing number of patients.
Even with better treatments, it’s clear they’re more focused on profits, treating people like numbers while hiding real cures, as they’ve done for decades.